Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Parker Laboratories

Manufactures medical ultrasound and electromedical contact media, including gels, solid gels, lotions and pads read more Featured Products: More products

Download Mobile App




Standardized Ultrasound-Guided PIV Insertions Improve Outcomes and Reduce Costs

By HospiMedica International staff writers
Posted on 06 Oct 2022

The use of ultrasound raises significant challenges: the presence of both the ultrasound probe and gel on at the sterile insertion site can contribute to contamination. More...

In addition, gel requires difficult clean up, and any gel left on the skin reduces the adherence of the dressing, increasing the chances of dressing failure. Now, a new study has shown that standardizing ultrasound-guided peripheral intravenous (PIV) insertions in a hospital setting using an innovative sterile barrier dressing reduced costs by 73% and staff time for insertions by 50%, while also improving both patient and nursing staff satisfaction.

The study by PICC Excellence (St Hartwell, GA, USA) was done at a medium-sized hospital with 245 beds and an emergency department that sees about 160 patients per day. A five-member vascular access team manages about 90 ultrasound-guided insertions per month. As part of a quality improvement initiative, researchers evaluated existing procedures for ultrasound-guided PIV insertions. They found significant procedural and supply variations among the departments. While the hospital did consistently use a Central Line Dressing Kit for each insertion, researchers observed that inserters wasted some of the more expensive components of the Kit. In addition, patients reported dissatisfaction because some insertions required multiple attempts.

To test possible solutions to these problems, the hospital switched to a standardized approach using an intravenous Start Kit with a sterile barrier ultrasound dressing called UltraDrape from Parker Laboratories Inc. (Fairfield, NJ, USA). In the standardized procedure, inserters first mark the selected site and apply the folded UltraDrape dressing to the skin. The ultrasound gel is applied to the back side of the dressing for ultrasound probe position and guidance during the insertion. Finally, the gel layer of the dressing is lifted off, and the dressing pulled down over the catheter, creating a sterile transparent dressing cover.

When the hospital switched to the standardized procedure, the data collected demonstrated impressive results. The average cost of supplies per insertion dropped from USD 25.32 to USD 6.71, which would add up to savings of more than USD 20,000 per year. In addition, the time required for each insertion was reduced from 6.51-12.14 minutes to just 3.2-4.25 minutes. Moreover, both patients and staff reported being far happier because of quicker insertions and fewer failed attempts. UltraDrape is simple to use, cost effective and faster than using standard probe covers. Using ultrasound to guide PIV insertions also improves the success rate for insertions, especially for patients with more co-morbidities requiring special skill with visualization technology.

“Our study shows that it is possible to improve outcomes and procedures for ultrasound-guided PIV insertions while also significantly cutting costs and staff time and reducing waste,” said Dr. Nancy Moureau, CEO of PICC Excellence and an internationally recognized expert and consultant in vascular access. “These results suggest that hospitals should consider more widespread use of the standardized UltraDrape dressing procedure.”

“It is the only dressing that separates the gel from the insertion site and that removes the gel after insertion, while providing sterile probe protection,” added Moureau. “For the estimated 12 million ultrasound-guided PIV insertions done each year in North America, it offers a win-win solution, simplifying and speeding up the procedure while reducing costs and time.”

“The UltraDrape dressing enables a level of standardization that simplifies the procedure while ensuring that sterile conditions are maintained,” said co-author Pam Pressnall. “This helped us achieve a level of efficiency that allows us to perform more ultrasound-guided patient insertions in fewer attempts, resulting in happier patients and nursing staff.”

Related Links:
PICC Excellence 
Parker Laboratories Inc. 


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Electrode Solution and Skin Prep
Signaspray
Autoclave
Advance
OR Table Accessory
Angular Accessory Rail
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.